• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Poster Presentations

2026 Poster Presentations

 

← Back to Previous Page

 

P096: SURGICAL APPROACHES AND PATIENT OUTCOMES IN JUGULAR FORAMEN SCHWANNOMAS: A META-ANALYSIS AND SYSTEMATIC REVIEW
Logan R Burrington1; Alexa R Lauinger, BS1; Anvita Mishra, BS1; Nicolas Kelhofer, BS1; Wael Hasseneen, MD, PhD2; 1Carle Illinois College of Medicine; 2Department of Neurosurgery, Carle Neuroscience Institute

Introduction: Jugular foramen schwannomas (JFS) are the second most common non-vestibular schwannoma behind trigeminal. They arise from cranial nerves IX, X, or XI, and although it can be difficult to differentiate which nerve the tumor arises from, the vagus nerve has been the most commonly described. Their complex location and proximity to critical neurovascular structures make resection difficult, with a high risk of postoperative lower cranial nerve deficits. Several surgical approaches have been described to maximize resection while minimizing morbidity. This review analyzes surgical strategies and outcomes in JFS management.

Methods: A comprehensive review of the literature was completed using PubMed, Scopus, and Web of Science for terms related to JFS and postoperative outcomes. Exclusion criteria include non-English full-length texts, systematic or literature reviews, and meta-analyses.

Results: From 383 initial unique articles, 25 met all inclusion criteria with 636 total patients (n = 83/49/7/497 CN IX/X/XI/Unknown JFS). Mean age at presentation was 40.8 years (53% female). The most common presenting symptoms were hearing loss (29%), dysphagia (23%), hoarseness (20%), and ataxia (15%). Gross total resection (GTR) was reported in 65% of cases, with subtotal or near total resection in the remainder. Recurrence or progression following resection was 8% over a mean follow-up of 35 months. The retrosigmoid approach was the most frequently utilized, followed by far or extreme-lateral, anterolateral, and then combined approach techniques. Combined approach techniques and radiosurgery were commonly employed for subtotal resections. The most common postoperative complications were new or worsening dysphagia, hoarseness, facial nerve palsy, and aspiration pneumonia. Mortality was rare (<1%).

Conclusions: Management of JFS is challenging given their proximity to critical neurovascular structures. Although GTR is possible, it carries significant risk of new cranial nerve deficits. Approach selection should be individualized to tumor configuration and preoperative function. A tailored multimodal strategy—including combined approaches and subtotal resection with radiosurgery when appropriate—offers the best balance between oncologic control and preservation of function. Standardized outcome reporting and prospective studies are needed to refine treatment algorithms.

View Poster

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved